Stay updated on Pediatric Dulaglutide Study in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Pediatric Dulaglutide Study in Type 2 Diabetes Clinical Trial page.

Latest updates to the Pediatric Dulaglutide Study in Type 2 Diabetes Clinical Trial page
- Check5 days agoChange DetectedThe study record for a completed trial of dulaglutide in children and adolescents with type 2 diabetes is available, including its design, outcomes, eligibility criteria, and locations. The record also provides individual-participant-data sharing details and study documents.SummaryDifference87%

- Check12 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA site-wide notice about NIH website changes appears above the ClinicalTrials.gov 403 error page. The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check40 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check47 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating access to the study record is blocked.SummaryDifference0.5%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study details with an access-denied message.SummaryDifference19%

Stay in the know with updates to Pediatric Dulaglutide Study in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Dulaglutide Study in Type 2 Diabetes Clinical Trial page.